These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 176185)

  • 1. Use of horseradish peroxidase to study the antagonism of Clostridium welchii (Cl. perfringens) type D epsilon toxin in mice by the formalinized epsilon prototoxin.
    Buxton D
    J Comp Pathol; 1976 Jan; 86(1):67-72. PubMed ID: 176185
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzymatic activation of Clostridium perfringens epsilon prototoxin and some biological properties of activated toxin.
    Worthington RW; Mülders MS; Van Rensburg JJ
    Onderstepoort J Vet Res; 1973 Dec; 40(4):151-4. PubMed ID: 4369993
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of lesions produced in the brains of colostrum deprived lambs by Clostridium welchii (Cl. perfringens) type D toxin.
    Buxton D; Morgan KT
    J Comp Pathol; 1976 Jul; 86(3):435-47. PubMed ID: 181408
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular leakage produced in the brains of mice by Clostridium welchii type D toxin.
    Morgan KT; Kelly BG; Buxton D
    J Comp Pathol; 1975 Jul; 85(3):461-6. PubMed ID: 167060
    [No Abstract]   [Full Text] [Related]  

  • 5. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides.
    Minami J; Katayama S; Matsushita O; Matsushita C; Okabe A
    Microbiol Immunol; 1997; 41(7):527-35. PubMed ID: 9272698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on epsilon-prototoxin of Clostridium perfringens type D. I. Purification methods: evidence for multiple forms of epsilon-prototoxin.
    Habeeb AF
    Arch Biochem Biophys; 1969 Mar; 130(1):430-40. PubMed ID: 4305163
    [No Abstract]   [Full Text] [Related]  

  • 7. The antigenic efficiency of Cl. welchii epsilon toxin and toxoid after treatment with trypsin.
    BATTY L; GLENNY AT
    Br J Exp Pathol; 1948 Apr; 29(2):141-8. PubMed ID: 18868964
    [No Abstract]   [Full Text] [Related]  

  • 8. Crystalline epsilon-prototoxin from Clostridium welchii.
    THOMSON RO
    Nature; 1962 Jan; 193():69-70. PubMed ID: 13920984
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of an immunoperoxidase technique to investigate by light and electron microscopy the sites of binding of Clostridium welchii type-D epsilon toxin in mice.
    Buxton D
    J Med Microbiol; 1978 Aug; 11(3):289-92. PubMed ID: 210278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The International Reference Preparations of Clostridium welchii (C. perfringens) beta and epsilon toxoids.
    Davidson I; Gray AK; Hebert CN; Lesslie IW
    Bull World Health Organ; 1978; 56(4):641-8. PubMed ID: 215337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino groups in Clostridium perfringens epsilon prototoxin and epsilon toxin.
    Sakurai J; Nagahama M
    Microb Pathog; 1986 Oct; 1(5):417-23. PubMed ID: 2907772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha toxoid of Clostridium perfringens. I. Purification and toxoiding of alpha toxin of C. perfringens.
    Ito A
    Jpn J Med Sci Biol; 1968 Dec; 21(6):379-91. PubMed ID: 4306752
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution of labeled Clostridium perfringens epsilon toxin in mice.
    Nagahama M; Sakurai J
    Toxicon; 1991; 29(2):211-7. PubMed ID: 2048139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational studies on modified proteins and peptides. VII. Conformation of epsilon-prototoxin and epsilon-toxin from Clostridium perfringens. Conformational changes associated with toxicity.
    Habeeb AF; Lee CL; Atassi MZ
    Biochim Biophys Acta; 1973 Oct; 322(2):245-50. PubMed ID: 4358084
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenic response in cattle to Clostridium welchii type D vaccine.
    Thompson JJ; Liardet DM
    N Z Vet J; 1966 Aug; 14(8):126-7. PubMed ID: 4292131
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential conformational environment of tryptophan in epsilon native prototoxin and active toxin from Clostridium perfringens type D.
    Kumar A; Kumar S; Sarma Dagger PV; Sharma Double Dagger AK
    J Biochem Mol Biol Biophys; 2002 Apr; 6(2):147-50. PubMed ID: 12186772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium perfringens type D epsilon prototoxin. Some chemical, immunological and biological properties of a highly purified prototoxin.
    Worthington RW; Mülders MS; Van Rensburg JJ
    Onderstepoort J Vet Res; 1973 Dec; 40(4):143-9. PubMed ID: 4369870
    [No Abstract]   [Full Text] [Related]  

  • 18. The alpha antitoxin content of the international reference preparations of Clostridium welchii types B and D antitoxins.
    SKULBERG A; VAN HEYNINGEN WE
    Bull World Health Organ; 1956; 14(3):557-66. PubMed ID: 13342930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural studies on epsilon-prototoxin of Clostridium perfringens type D. Localization of the site of tryptic scission necessary for activation to epsilon-toxin.
    Bhown AS; Habeerb AF
    Biochem Biophys Res Commun; 1977 Oct; 78(3):889-96. PubMed ID: 199192
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of potential protective immunity against enterotoxemia in calves by single or multiple recombinant Clostridium perfringens toxoids.
    Jiang Z; De Y; Chang J; Wang F; Yu L
    Microbiol Immunol; 2014 Nov; 58(11):621-7. PubMed ID: 25197030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.